These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23558161)

  • 1. High-resolution transrectal ultrasound: pilot study of a novel technique for imaging clinically localized prostate cancer.
    Pavlovich CP; Cornish TC; Mullins JK; Fradin J; Mettee LZ; Connor JT; Reese AC; Askin FB; Luck R; Epstein JI; Burke HB
    Urol Oncol; 2014 Jan; 32(1):34.e27-32. PubMed ID: 23558161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies.
    Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S
    BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™).
    Simmons LA; Autier P; Zát'ura F; Braeckman J; Peltier A; Romic I; Stenzl A; Treurnicht K; Walker T; Nir D; Moore CM; Emberton M
    BJU Int; 2012 Jul; 110(1):28-35. PubMed ID: 22093966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.
    Washington SL; Bonham M; Whitson JM; Cowan JE; Carroll PR
    BJU Int; 2012 Jul; 110(1):50-5. PubMed ID: 22077660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced transrectal ultrasonography: measurement of prostate cancer tumor size and correlation with radical prostatectomy specimens.
    Qi TY; Chen YQ; Jiang J; Zhu YK; Yao XH; Qi J
    Int J Urol; 2013 Nov; 20(11):1085-91. PubMed ID: 23551612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer.
    Seitz M; Gratzke C; Schlenker B; Buchner A; Karl A; Roosen A; Singer BB; Bastian PJ; Ergün S; Stief CG; Reich O; Tilki D
    Urol Oncol; 2011; 29(3):295-301. PubMed ID: 19523857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of PSA density by 3 imaging modalities and its correlation with the PSA density of radical prostatectomy specimen.
    Varkarakis I; Zarkadoulias A; Bourdoumis A; Chatzidarellis E; Antoniou N; Deliveliotis C
    Urol Oncol; 2013 Oct; 31(7):1038-42. PubMed ID: 22196747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
    Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
    J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer: 1.5 T endo-coil dynamic contrast-enhanced MRI and MR spectroscopy--correlation with prostate biopsy and prostatectomy histopathological data.
    Chabanova E; Balslev I; Logager V; Hansen A; Jakobsen H; Kromann-Andersen B; Norgaard N; Horn T; Thomsen HS
    Eur J Radiol; 2011 Nov; 80(2):292-6. PubMed ID: 20708869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of transrectal ultrasound scan of the prostate with sector biopsies for 323 New Zealand men with suspicion of prostate cancer.
    Smart R
    N Z Med J; 1999 Dec; 112(1101):465-9. PubMed ID: 10678211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy.
    Salomon G; Köllerman J; Thederan I; Chun FK; Budäus L; Schlomm T; Isbarn H; Heinzer H; Huland H; Graefen M
    Eur Urol; 2008 Dec; 54(6):1354-62. PubMed ID: 18374470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staging of prostate cancer using 3-dimensional transrectal ultrasound images: a pilot study.
    Garg S; Fortling B; Chadwick D; Robinson MC; Hamdy FC
    J Urol; 1999 Oct; 162(4):1318-21. PubMed ID: 10492188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative predictive value of systematic ultrasound-guided prostate biopsy: which tumours do we miss?
    Köpke T; Oberpenning F; Bettendorf O; Eltze E; Herrmann E; Hertle L; Weining C; Wulfing C; Semjonow A
    Anticancer Res; 2010 May; 30(5):1823-7. PubMed ID: 20592386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis.
    Ellis JH; Tempany C; Sarin MS; Gatsonis C; Rifkin MD; McNeil BJ
    AJR Am J Roentgenol; 1994 Apr; 162(4):865-72. PubMed ID: 8141009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer.
    Zhao HX; Xia CX; Yin HX; Guo N; Zhu Q
    Eur J Radiol; 2013 Nov; 82(11):e641-7. PubMed ID: 23916578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
    Rinnab L; Blumstein NM; Mottaghy FM; Hautmann RE; Küfer R; Hohl K; Reske SN
    BJU Int; 2007 Jun; 99(6):1421-6. PubMed ID: 17355373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-Human Ultrasound Molecular Imaging With a VEGFR2-Specific Ultrasound Molecular Contrast Agent (BR55) in Prostate Cancer: A Safety and Feasibility Pilot Study.
    Smeenge M; Tranquart F; Mannaerts CK; de Reijke TM; van de Vijver MJ; Laguna MP; Pochon S; de la Rosette JJMCH; Wijkstra H
    Invest Radiol; 2017 Jul; 52(7):419-427. PubMed ID: 28257340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Method of the connection HMRS and TRUS images--improvement of effectiveness transrectal core biopsy of the prostate].
    Lipczyński W
    Przegl Lek; 2012; 69(5):176-80. PubMed ID: 23050412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.